Print

BioAlliance Pharma: New Agreement Signed for the Distribution of Loramyc® in Iran With Shafayab Gostar  
10/18/2012 4:03:09 PM

PARIS--(BUSINESS WIRE)--Regulatory News: BioAlliance Pharma SA (Euronext Paris - BIO), an innovative Company dedicated to the development of orphan oncology products and to supportive care products, announces the signature of an agreement* with the Company Shafayab Gostar to distribute Loramyc® in Iran (miconazole Lauriad™ mucoadhesive buccal tablet for the treatment of oropharyngeal candidiasis in immunocompromised patients).